Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease with unknown etiology that can be characterized by the presence of demyelinated lesions. Prevailing treatment protocols in MS rely on the modulation of the inflammatory process but do not impact disease progression. Remyeli...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schaik, Pauline E. M., Zuhorn, Inge S., Baron, Wia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368816/
https://www.ncbi.nlm.nih.gov/pubmed/35955549
http://dx.doi.org/10.3390/ijms23158418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368816/
https://www.ncbi.nlm.nih.gov/pubmed/35955549
http://dx.doi.org/10.3390/ijms23158418

Ejemplares similares